Venus Concept (VERO) Set to Announce Earnings on Thursday

Venus Concept (NASDAQ:VEROGet Rating) is scheduled to be releasing its earnings data after the market closes on Thursday, May 12th. Analysts expect Venus Concept to post earnings of ($0.10) per share for the quarter. Venus Concept has set its FY 2022 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Venus Concept (NASDAQ:VEROGet Rating) last released its quarterly earnings data on Monday, March 28th. The company reported ($0.08) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.12) by $0.04. The company had revenue of $32.63 million for the quarter, compared to the consensus estimate of $32.50 million. Venus Concept had a negative return on equity of 72.05% and a negative net margin of 21.79%. During the same period in the previous year, the business earned ($0.22) earnings per share. On average, analysts expect Venus Concept to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

NASDAQ VERO opened at $0.86 on Thursday. The company has a current ratio of 3.43, a quick ratio of 2.77 and a debt-to-equity ratio of 1.86. The stock’s 50 day moving average is $1.32 and its two-hundred day moving average is $1.53. The company has a market capitalization of $55.17 million, a price-to-earnings ratio of -2.05 and a beta of 2.28. Venus Concept has a 1-year low of $0.75 and a 1-year high of $3.37.

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Virtu Financial LLC bought a new position in shares of Venus Concept in the fourth quarter valued at approximately $38,000. Citadel Advisors LLC raised its stake in shares of Venus Concept by 102.3% in the second quarter. Citadel Advisors LLC now owns 32,950 shares of the company’s stock valued at $103,000 after acquiring an additional 16,663 shares during the last quarter. Millennium Management LLC raised its stake in shares of Venus Concept by 70.8% in the fourth quarter. Millennium Management LLC now owns 107,827 shares of the company’s stock valued at $183,000 after acquiring an additional 44,705 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Venus Concept by 49.5% in the third quarter. Dimensional Fund Advisors LP now owns 173,477 shares of the company’s stock valued at $435,000 after acquiring an additional 57,425 shares during the last quarter. Finally, Morgan Stanley raised its stake in shares of Venus Concept by 1,412.7% in the second quarter. Morgan Stanley now owns 172,973 shares of the company’s stock valued at $537,000 after acquiring an additional 161,538 shares during the last quarter.

Separately, Zacks Investment Research downgraded Venus Concept from a “buy” rating to a “hold” rating in a report on Tuesday, March 22nd.

About Venus Concept (Get Rating)

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

Featured Articles

Earnings History for Venus Concept (NASDAQ:VERO)

Receive News & Ratings for Venus Concept Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venus Concept and related companies with MarketBeat.com's FREE daily email newsletter.